Related Experiment Video

Updated: Aug 14, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Endocrine manipulation of human prostatic cancer: state of the art

M Serio1, E Calabresi, R Salerno

  • 1Endocrinology Unit, Clinical Physiopathology Department University of Florence, Italy.

Journal of Chemotherapy (Florence, Italy)
|July 1, 1989
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Related Experiment Videos

Last Updated: Aug 14, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Articles linked to this work by shared authors, journal, and citation graph.

Multi-institutional study using sbrt to treat mediastinal and hilar lymphadenopathy.

Clinical & experimental metastasis·2024

Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn's disease: results from a large Italian cohort study.

European review for medical and pharmacological sciences·2021

Measurement of associated Z + charm production in proton-proton collisions at .

The European physical journal. C, Particles and fields·2019

Measurements of the production cross section and the branching fraction, and constraints on anomalous triple gauge couplings at .

The European physical journal. C, Particles and fields·2019

Combination of Searches for Higgs Boson Pair Production in Proton-Proton Collisions at sqrt[s]=13 TeV.

Physical review letters·2019

Measurement of associated production of a boson and a charm quark in proton-proton collisions at .

The European physical journal. C, Particles and fields·2019

Longitudinal acquisition and infection risk associated with multidrug-resistant organisms and Candida colonization in intensive care unit patients.

Journal of chemotherapy (Florence, Italy)·2026

Circular RNAs: key regulators and mechanistic insights in breast cancer drug resistance.

Journal of chemotherapy (Florence, Italy)·2026

Tumor resistance to protein kinase inhibitors.

Journal of chemotherapy (Florence, Italy)·2026

First-line therapy and maintenance outcomes in Chinese patients with marginal zone lymphoma: a multicenter retrospective analysis with prognostic implications for chemotherapy decision-making.

Journal of chemotherapy (Florence, Italy)·2026

The epigenetic regulator ALKBH5 facilitates the early adaptation of hepatocellular carcinoma cells to sorafenib treatment.

Journal of chemotherapy (Florence, Italy)·2026

Targeting glutaminase (GLS) to suppress CXCL8 secretion and sensitize esophageal squamous cell carcinoma to immunotherapy.

Journal of chemotherapy (Florence, Italy)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us